06.30.07
Posted in Uncategorized at 8:00 pm by Cancer / Oncology News From Medical News Today
Treatment with intravenous bisphosphonates - drugs used to reduce harm done to bones by cancer or cancer therapy - increases the risk of jaw or facial bone disease or infection, a large-scale comparative study by researchers at the University of Texas Medical Branch at Galveston (UTMB) has found. [click link for full article]
Permalink
Posted in Uncategorized at 5:00 pm by Lung Cancer News From Medical News Today
Dimitrios Trichopoulos, Vincent L. Gregory Professor of Cancer Prevention at the Harvard School of Public Health (HSPH), was one of three recipients of a medal of honor from the International Agency for Research on Cancer (IARC), part of the World Health Organization. The award was presented at the IARC Headquarters in Lyon, France.Trichopoulos has conducted seminal work linking passive or "second-hand" smoking to lung cancer. [click link for full article]
Permalink
Posted in Uncategorized at 5:00 pm by Cancer / Oncology News From Medical News Today
Dimitrios Trichopoulos, Vincent L. Gregory Professor of Cancer Prevention at the Harvard School of Public Health (HSPH), was one of three recipients of a medal of honor from the International Agency for Research on Cancer (IARC), part of the World Health Organization. The award was presented at the IARC Headquarters in Lyon, France.Trichopoulos has conducted seminal work linking passive or "second-hand" smoking to lung cancer. [click link for full article]
Permalink
Posted in Uncategorized at 3:00 pm by Cancer / Oncology News From Medical News Today
The June issue of Elsevier’s Community Oncology takes an in-depth look at the charge that ESAs, generally considered vital to cancer patients’ quality of life, are overprescribed for profit. Scientists, oncologists, and critics of oncologists are in a heated debate now over the use of ESAs, or erythropoiesis-stimulating agents - drugs that fight anemia by boosting levels of oxygen-carrying red blood cells and the protein hemoglobin. [click link for full article]
Permalink
Posted in Uncategorized at 10:00 am by Cancer / Oncology News From Medical News Today
For the first time in history three major European organisations involved in urological malignant disorders - the European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the European Association of Urology (EAU) - have joined forces in setting up a meeting to present and discuss the latest state-of-the-art issues and controversies in this rapidly evolving field. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Lung Cancer News From Medical News Today
Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer.The compound, called beta-lapachone, has shown promising anti-cancer properties and is currently being used in a clinical trial to examine its effectiveness against pancreatic cancer in humans. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Lung Cancer News From Medical News Today
Researchers at UT Southwestern Medical Center have determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells, findings that also suggest a novel treatment for the most common type of lung cancer.The compound, called beta-lapachone, has shown promising anti-cancer properties and is currently being used in a clinical trial to examine its effectiveness against pancreatic cancer in humans. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Cancer / Oncology News From Medical News Today
A synthetic version of a molecule found in the egg cells of the Northern Leopard frog (Rana pipiens) could provide the world with the first drug treatment for brain tumours. Known as Amphinase, the molecule recognises the sugary coating found on a tumour cell and binds to its surface before invading the cell and inactivating the RNA it contains, causing the tumour to die. [click link for full article]
Permalink
06.29.07
Posted in Uncategorized at 9:40 pm by Yahoo! Health: Cancer News
FRIDAY, June 29 (HealthDay News) - Less invasive lung surgery should become the first option for cancer patients, U.S. experts say.
Permalink
Posted in Uncategorized at 2:00 am by Breast Cancer News From Medical News Today
NOVIAN Health Inc. has developed an Interstitial Laser Therapy (ILT) device. In its initial application, the device, used to treat fibroadenomas (benign tumors) of the breast with tumor sizes up to 20 mm, was granted clearance from the U.S. Food and Drug Administration on May 2, 2007. "We are extremely pleased to have received FDA clearance, " said Chip Appelbaum, President and CEO of NOVIAN Health. [click link for full article]
Permalink
« Previous entries
